Tremelimumab – Uses, Side Effects, Dosage & Drug Information | MedInfo World | MedInfo World
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Tremelimumab
CTLA-4-directed Blocking Antibody [EPC]
1 Drug2 Variants
Clinical Data
Name
Tremelimumab
Raw Name
TREMELIMUMAB
Category
CTLA-4-directed Blocking Antibody [EPC]
Drug Count
1
Variant Count
2
Drug Classes
CTLA-4-directed Blocking Antibody [EPC]
Important Notice
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Tremelimumab.